FDA Approves Dual-Energy Catheter Ablation Platform - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves Dual-Energy Catheter Ablation Platform

The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.

  • By

  • Kathryn Wighton

  • July 8, 2026

  • 2 min

Share

  • 1

    The FDA has approved the Dual Energy THERMOCOOL SMARTTOUCH SF Platform from Johnson & Johnson for catheter ablation.

  • 2

    This platform allows electrophysiologists to deliver both pulsed field and radiofrequency energy through a single catheter.

  • 3

    The platform is built on the existing THERMOCOOL SMARTTOUCH SF catheter platform, used in over one million US patient treatments.

  • 4

    The Dual Energy platform integrates with the CARTO ecosystem for enhanced mapping, imaging, and guidance.

  • 5

    First US procedures using the platform are expected to begin this summer as part of a phased commercial rollout.

Original Source(s)

FDA Approves Dual-Energy Catheter Ablation Platform

  • by Kathryn Wighton

  • July 8, 2026

Related Content

Hemodynamic Instability in Intubation May Be Predictable

Narrative review describes how physiologic stressors accumulate from induction through postintubation care and may contribute to cardiovascular deterioration during airway management.

Diagnosis-to-Ablation Time and Atrial Arrhythmia Recurrence After Ablation

Does Weight Loss Intervention Improve Persistent AF?

Randomized trial found significant weight loss did not improve atrial fibrillation severity or burden in older patients with persistent disease.